chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Lethargy, Malaise, Pain
Clinical narrative: Could not breath well when lay down; Started wheeze; Felt Lethargic; Coughing/Cough; Feels ache/pain; Feels sick; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Could not breath well when lay down), WHEEZING (Started wheeze), LETHARGY (Felt Lethargic), COUGH (Coughing/Cough) and PAIN (Feels ache/pain) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced DYSPNOEA (Could not breath well when lay down), WHEEZING (Started wheeze), LETHARGY (Felt Lethargic), COUGH (Coughing/Cough), PAIN (Feels ache/pain) and MALAISE (Feels sick). At the time of the report, DYSPNOEA (Could not breath well when lay down), WHEEZING (Started wheeze), LETHARGY (Felt Lethargic), COUGH (Coughing/Cough), PAIN (Feels ache/pain) and MALAISE (Feels sick) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient feels little better and then worst. Patient is not on concomitant medication. Treatment information includes Antibiotics and steroids.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: Could not breath well when lay down; Started wheeze; Felt Lethargic; Coughing/Cough; Feels ache/pain; Feels sick; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Could not breath well when lay down), WHEEZING (Started wheeze), LETHARGY (Felt Lethargic), COUGH (Coughing/Cough) and PAIN (Feels ache/pain) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced DYSPNOEA (Could not breath well when lay down), WHEEZING (Started wheeze), LETHARGY (Felt Lethargic), COUGH (Coughing/Cough), PAIN (Feels ache/pain) and MALAISE (Feels sick). At the time of the report, DYSPNOEA (Could not breath well when lay down), WHEEZING (Started wheeze), LETHARGY (Felt Lethargic), COUGH (Coughing/Cough), PAIN (Feels ache/pain) and MALAISE (Feels sick) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient feels little better and then worst. Patient is not on concomitant medication. Treatment information includes Antibiotics and steroids.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Patient states he had a list of side effects, nothing specific named; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Patient states he had a list of side effects, nothing specific named) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Patient states he had a list of side effects, nothing specific named). At the time of the report, VACCINATION COMPLICATION (Patient states he had a list of side effects, nothing specific named) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Skin discolouration, Vaccination site swelling
Clinical narrative: Toes hurt when she wore shoes; Both her big toes turned purple; Swollen spot on left arm at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Toes hurt when she wore shoes), SKIN DISCOLOURATION (Both her big toes turned purple) and VACCINATION SITE SWELLING (Swollen spot on left arm at injection site) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0081321A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Toes hurt when she wore shoes), SKIN DISCOLOURATION (Both her big toes turned purple) and VACCINATION SITE SWELLING (Swollen spot on left arm at injection site). At the time of the report, PAIN IN EXTREMITY (Toes hurt when she wore shoes), SKIN DISCOLOURATION (Both her big toes turned purple) and VACCINATION SITE SWELLING (Swollen spot on left arm at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Patient did not use any treatment for events
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Peripheral swelling
Clinical narrative: Swelling of the arm; Tiredness; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling of the arm), FATIGUE (Tiredness) and MYALGIA (Body aches) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling of the arm), FATIGUE (Tiredness) and MYALGIA (Body aches). At the time of the report, PERIPHERAL SWELLING (Swelling of the arm), FATIGUE (Tiredness) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided. Treatment information included Paracetamol but not specified for which dose it was taken.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling cold, Pain in extremity
Clinical narrative: Sore arm; Couldn't get warm; More tired/Feeling fatigued; Had chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), FEELING COLD (Couldn't get warm), FATIGUE (More tired/Feeling fatigued) and CHILLS (Had chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), FEELING COLD (Couldn't get warm), FATIGUE (More tired/Feeling fatigued) and CHILLS (Had chills). At the time of the report, PAIN IN EXTREMITY (Sore arm), FEELING COLD (Couldn't get warm), FATIGUE (More tired/Feeling fatigued) and CHILLS (Had chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product information was not provided Treatment information was not provided   This case was linked to MOD21-078105, MOD21-078105 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Additional information was received and new event sore arm was added.; Sender's Comments:  MOD21-078105:MOD-2021-080342 MOD21-078105:MOD-2021-080336
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received first dose on 12Mar2021, but not their second dose yet; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 12Mar2021, but not their second dose yet) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 12-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 12Mar2021, but not their second dose yet). On 12-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received first dose on 12Mar2021, but not their second dose yet) had resolved.            On an unspecified date, the patient received second dose of vaccine. Concomitant medications were not provided. Treatment information was not reported.    Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Product information updated.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Heart rate increased, Hypoaesthesia oral, Musculoskeletal stiffness, Nervousness
Clinical narrative: Area was warm to touch; Itching at the injection site; Redness at the injection site; Extreme tiredness; Nervous; Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb; Stick neck mostly on the left side; Slight fast heartbeat; Itching in the back, neck, chin ,scalp and slightly on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area was warm to touch), NERVOUSNESS (Nervous), HYPOAESTHESIA ORAL (Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb), MUSCULOSKELETAL STIFFNESS (Stick neck mostly on the left side) and HEART RATE INCREASED (Slight fast heartbeat) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced NERVOUSNESS (Nervous), HYPOAESTHESIA ORAL (Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb), MUSCULOSKELETAL STIFFNESS (Stick neck mostly on the left side), HEART RATE INCREASED (Slight fast heartbeat), PRURITUS (Itching in the back, neck, chin ,scalp and slightly on her left arm) and FATIGUE (Extreme tiredness). On 30-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 31-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Area was warm to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Injection site itching, at an unspecified dose and frequency. On 24-Mar-2021, NERVOUSNESS (Nervous), HYPOAESTHESIA ORAL (Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb), MUSCULOSKELETAL STIFFNESS (Stick neck mostly on the left side), HEART RATE INCREASED (Slight fast heartbeat), PRURITUS (Itching in the back, neck, chin ,scalp and slightly on her left arm) and FATIGUE (Extreme tiredness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Area was warm to touch), VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient believes herself to be an"allergic" person and describes this as an allergic reaction. Concomitant product information was not provided.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Area was warm to touch; Itching at the injection site; Redness at the injection site; Extreme tiredness; Nervous; Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb; Stick neck mostly on the left side; Slight fast heartbeat; Itching in the back, neck, chin ,scalp and slightly on her left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Area was warm to touch), NERVOUSNESS (Nervous), HYPOAESTHESIA ORAL (Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb), MUSCULOSKELETAL STIFFNESS (Stick neck mostly on the left side) and HEART RATE INCREASED (Slight fast heartbeat) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced NERVOUSNESS (Nervous), HYPOAESTHESIA ORAL (Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb), MUSCULOSKELETAL STIFFNESS (Stick neck mostly on the left side), HEART RATE INCREASED (Slight fast heartbeat), PRURITUS (Itching in the back, neck, chin ,scalp and slightly on her left arm) and FATIGUE (Extreme tiredness). On 30-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). On 31-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Area was warm to touch). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Injection site itching, at an unspecified dose and frequency. On 24-Mar-2021, NERVOUSNESS (Nervous), HYPOAESTHESIA ORAL (Weird sensation on upper left lip,as pins and needles and it felt like her lip was going numb), MUSCULOSKELETAL STIFFNESS (Stick neck mostly on the left side), HEART RATE INCREASED (Slight fast heartbeat), PRURITUS (Itching in the back, neck, chin ,scalp and slightly on her left arm) and FATIGUE (Extreme tiredness) had resolved. At the time of the report, VACCINATION SITE WARMTH (Area was warm to touch), VACCINATION SITE PRURITUS (Itching at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient believes herself to be an"allergic" person and describes this as an allergic reaction. Concomitant product information was not provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Lip swelling, Swelling face
Clinical narrative: feeling of numbness over the left side of the face; Developed swelling over the left side of the face; Developed swelling over the left side of the lips.; Feeling of numbness over the left side of the lips; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (feeling of numbness over the left side of the face), SWELLING FACE (Developed swelling over the left side of the face), LIP SWELLING (Developed swelling over the left side of the lips.) and HYPOAESTHESIA ORAL (Feeling of numbness over the left side of the lips) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A.) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced HYPOAESTHESIA (feeling of numbness over the left side of the face), SWELLING FACE (Developed swelling over the left side of the face), LIP SWELLING (Developed swelling over the left side of the lips.) and HYPOAESTHESIA ORAL (Feeling of numbness over the left side of the lips). At the time of the report, HYPOAESTHESIA (feeling of numbness over the left side of the face), SWELLING FACE (Developed swelling over the left side of the face), LIP SWELLING (Developed swelling over the left side of the lips.) and HYPOAESTHESIA ORAL (Feeling of numbness over the left side of the lips) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided. Concomitant medications were not provided.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dysuria
Clinical narrative: Trouble urinating; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Trouble urinating) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 038A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSURIA (Trouble urinating). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, DYSURIA (Trouble urinating) outcome was unknown. Not Provided          Concomitant product information was not provided. Action taken with mRNA-1273 in response to the events was not applicable
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Intentional product use issue, Pain in extremity, Pruritus, Rash
Clinical narrative: Second dose was not administered because of the reaction to first dose; Rash all over body; Hives on arms, hands and legs; Was very allergic to it; Itchy; Bottom of the feet are sore; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (Hives on arms, hands and legs), ALLERGY TO VACCINE (Was very allergic to it), PRURITUS (Itchy), PAIN IN EXTREMITY (Bottom of the feet are sore) and INTENTIONAL PRODUCT USE ISSUE (Second dose was not administered because of the reaction to first dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included SIMVASTATIN and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced URTICARIA (Hives on arms, hands and legs), ALLERGY TO VACCINE (Was very allergic to it), PRURITUS (Itchy), PAIN IN EXTREMITY (Bottom of the feet are sore) and RASH (Rash all over body). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Second dose was not administered because of the reaction to first dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives on arms, hands and legs) had not resolved, ALLERGY TO VACCINE (Was very allergic to it), PRURITUS (Itchy), PAIN IN EXTREMITY (Bottom of the feet are sore) and RASH (Rash all over body) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (Second dose was not administered because of the reaction to first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also included blood pressure medication. On 15-Apr-2021, the patient experienced PRURITUS (hands itch), the outcome unknown. The patient had applied a cream with steroids to treat the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Additional  information included reporter details(consumer),  new concomitant medications (simvastatin and Prilosec), new events (was very allergic to it, rash all over body, itchy hands itch and bottom of the feet are sore) were added.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Second dose was not administered because of the reaction to first dose; Rash all over body; Hives on arms, hands and legs; Was very allergic to it; Itchy; Bottom of the feet are sore; This spontaneous case was reported by a pharmacist and describes the occurrence of URTICARIA (Hives on arms, hands and legs), ALLERGY TO VACCINE (Was very allergic to it), PRURITUS (Itchy), PAIN IN EXTREMITY (Bottom of the feet are sore) and INTENTIONAL PRODUCT USE ISSUE (Second dose was not administered because of the reaction to first dose) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included SIMVASTATIN and OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced URTICARIA (Hives on arms, hands and legs), ALLERGY TO VACCINE (Was very allergic to it), PRURITUS (Itchy), PAIN IN EXTREMITY (Bottom of the feet are sore) and RASH (Rash all over body). On an unknown date, the patient experienced INTENTIONAL PRODUCT USE ISSUE (Second dose was not administered because of the reaction to first dose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Hives on arms, hands and legs) had not resolved, ALLERGY TO VACCINE (Was very allergic to it), PRURITUS (Itchy), PAIN IN EXTREMITY (Bottom of the feet are sore) and RASH (Rash all over body) outcome was unknown and INTENTIONAL PRODUCT USE ISSUE (Second dose was not administered because of the reaction to first dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication also included blood pressure medication. On 15-Apr-2021, the patient experienced PRURITUS (hands itch), the outcome unknown. The patient had applied a cream with steroids to treat the symptoms.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Additional  information included reporter details(consumer),  new concomitant medications (simvastatin and Prilosec), new events (was very allergic to it, rash all over body, itchy hands itch and bottom of the feet are sore) were added.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Vaccination site pain
Clinical narrative: Elevated heart rate; Pain in injection site area; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Elevated heart rate) and VACCINATION SITE PAIN (Pain in injection site area) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 21 (indecipherable) and 025BUN) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Apr-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate) and VACCINATION SITE PAIN (Pain in injection site area). On 17-Apr-2021, HEART RATE INCREASED (Elevated heart rate) and VACCINATION SITE PAIN (Pain in injection site area) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Apr-2021, Heart rate: high (High) upto 110 bpm, elevated for a while.         No Concomitant product use was reported. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-080063 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-080063:dose 1
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort
Clinical narrative: Problems with stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Problems with stomach) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (Problems with stomach). At the time of the report, ABDOMINAL DISCOMFORT (Problems with stomach) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: Added patient age. Added event outcome updated.
Age: 86.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site mass, Vaccination site pruritus
Clinical narrative: There's lump underneath, left arm; Left arm is a little bit pink; Left arm is itchy; This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE MASS (There's lump underneath, left arm), VACCINATION SITE DISCOLOURATION (Left arm is a little bit pink) and VACCINATION SITE PRURITUS (Left arm is itchy) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), IBUPROFEN, SIMVASTATIN, ASPIRIN [ACETYLSALICYLIC ACID], CALCIUM and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Apr-2021, the patient experienced VACCINATION SITE MASS (There's lump underneath, left arm), VACCINATION SITE DISCOLOURATION (Left arm is a little bit pink) and VACCINATION SITE PRURITUS (Left arm is itchy). At the time of the report, VACCINATION SITE MASS (There's lump underneath, left arm), VACCINATION SITE DISCOLOURATION (Left arm is a little bit pink) and VACCINATION SITE PRURITUS (Left arm is itchy) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Follow up contains NNI On 22-May-2021: Additional information received and Outcome of the events updated from Unknown to recovering
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 2nd dose Moderna COVID19 vaccine not received within timeframe; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna COVID19 vaccine not received within timeframe) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna COVID19 vaccine not received within timeframe). On 01-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose Moderna COVID19 vaccine not received within timeframe) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided by the reporter. Treatment information was not provided. Upon in internal review on 21 May 2021, the age was corrected to an unknown age.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Feeling abnormal, Feeling hot
Clinical narrative: Intermittent tingling of her lips; Red Bumps on tongue; Tongue became swollen; Tongue feeling "like it has hairs on it"; Red palms; Hot palms; Itchy palms; Headache; Joint pain,Ankle pain; Throwing up; Nausea; Chills; Woke up at 3 am; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Woke up at 3 am), PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue), SWOLLEN TONGUE (Tongue became swollen) and FEELING ABNORMAL (Tongue feeling "like it has hairs on it") in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Hospitalization in Dec 2020). Concurrent medical conditions included Asthma, Epstein-Barr virus infection and Drug allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D NOS for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced SLEEP DISORDER (Woke up at 3 am) and FATIGUE (Tiredness). On 14-Apr-2021, the patient experienced FEELING ABNORMAL (Tongue feeling "like it has hairs on it"), PALMAR ERYTHEMA (Red palms), FEELING HOT (Hot palms), PRURITUS (Itchy palms), HEADACHE (Headache), ARTHRALGIA (Joint pain,Ankle pain), VOMITING (Throwing up), NAUSEA (Nausea) and CHILLS (Chills). On 15-Apr-2021, the patient experienced PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue) and SWOLLEN TONGUE (Tongue became swollen). The patient was treated with NYSTATIN at an unspecified dose and frequency. On 19-Apr-2021, PALMAR ERYTHEMA (Red palms), FEELING HOT (Hot palms), PRURITUS (Itchy palms), HEADACHE (Headache), ARTHRALGIA (Joint pain,Ankle pain), VOMITING (Throwing up), NAUSEA (Nausea) and CHILLS (Chills) had resolved. At the time of the report, SLEEP DISORDER (Woke up at 3 am), PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue), SWOLLEN TONGUE (Tongue became swollen), FEELING ABNORMAL (Tongue feeling "like it has hairs on it") and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports she was hospitalized with COVID-19 for several days and administered IV doxycycline, steroids, Remdesivir, and albuterol in December 2020.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Palmar erythema, Paraesthesia oral, Pruritus
Clinical narrative: Intermittent tingling of her lips; Red Bumps on tongue; Tongue became swollen; Tongue feeling "like it has hairs on it"; Red palms; Hot palms; Itchy palms; Headache; Joint pain,Ankle pain; Throwing up; Nausea; Chills; Woke up at 3 am; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Woke up at 3 am), PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue), SWOLLEN TONGUE (Tongue became swollen) and FEELING ABNORMAL (Tongue feeling "like it has hairs on it") in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Hospitalization in Dec 2020). Concurrent medical conditions included Asthma, Epstein-Barr virus infection and Drug allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D NOS for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced SLEEP DISORDER (Woke up at 3 am) and FATIGUE (Tiredness). On 14-Apr-2021, the patient experienced FEELING ABNORMAL (Tongue feeling "like it has hairs on it"), PALMAR ERYTHEMA (Red palms), FEELING HOT (Hot palms), PRURITUS (Itchy palms), HEADACHE (Headache), ARTHRALGIA (Joint pain,Ankle pain), VOMITING (Throwing up), NAUSEA (Nausea) and CHILLS (Chills). On 15-Apr-2021, the patient experienced PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue) and SWOLLEN TONGUE (Tongue became swollen). The patient was treated with NYSTATIN at an unspecified dose and frequency. On 19-Apr-2021, PALMAR ERYTHEMA (Red palms), FEELING HOT (Hot palms), PRURITUS (Itchy palms), HEADACHE (Headache), ARTHRALGIA (Joint pain,Ankle pain), VOMITING (Throwing up), NAUSEA (Nausea) and CHILLS (Chills) had resolved. At the time of the report, SLEEP DISORDER (Woke up at 3 am), PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue), SWOLLEN TONGUE (Tongue became swollen), FEELING ABNORMAL (Tongue feeling "like it has hairs on it") and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports she was hospitalized with COVID-19 for several days and administered IV doxycycline, steroids, Remdesivir, and albuterol in December 2020.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder, Swollen tongue, Tongue disorder, Vomiting
Clinical narrative: Intermittent tingling of her lips; Red Bumps on tongue; Tongue became swollen; Tongue feeling "like it has hairs on it"; Red palms; Hot palms; Itchy palms; Headache; Joint pain,Ankle pain; Throwing up; Nausea; Chills; Woke up at 3 am; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (Woke up at 3 am), PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue), SWOLLEN TONGUE (Tongue became swollen) and FEELING ABNORMAL (Tongue feeling "like it has hairs on it") in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Hospitalization in Dec 2020). Concurrent medical conditions included Asthma, Epstein-Barr virus infection and Drug allergy. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and VITAMIN D NOS for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced SLEEP DISORDER (Woke up at 3 am) and FATIGUE (Tiredness). On 14-Apr-2021, the patient experienced FEELING ABNORMAL (Tongue feeling "like it has hairs on it"), PALMAR ERYTHEMA (Red palms), FEELING HOT (Hot palms), PRURITUS (Itchy palms), HEADACHE (Headache), ARTHRALGIA (Joint pain,Ankle pain), VOMITING (Throwing up), NAUSEA (Nausea) and CHILLS (Chills). On 15-Apr-2021, the patient experienced PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue) and SWOLLEN TONGUE (Tongue became swollen). The patient was treated with NYSTATIN at an unspecified dose and frequency. On 19-Apr-2021, PALMAR ERYTHEMA (Red palms), FEELING HOT (Hot palms), PRURITUS (Itchy palms), HEADACHE (Headache), ARTHRALGIA (Joint pain,Ankle pain), VOMITING (Throwing up), NAUSEA (Nausea) and CHILLS (Chills) had resolved. At the time of the report, SLEEP DISORDER (Woke up at 3 am), PARAESTHESIA ORAL (Intermittent tingling of her lips), TONGUE DISORDER (Red Bumps on tongue), SWOLLEN TONGUE (Tongue became swollen), FEELING ABNORMAL (Tongue feeling "like it has hairs on it") and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports she was hospitalized with COVID-19 for several days and administered IV doxycycline, steroids, Remdesivir, and albuterol in December 2020.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity
Clinical narrative: Headache; Muscle pain in leg; Sore arm for a day and a half; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm for a day and a half), HEADACHE (Headache) and MYALGIA (Muscle pain in leg) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced PAIN IN EXTREMITY (Sore arm for a day and a half). On 17-Apr-2021, the patient experienced HEADACHE (Headache) and MYALGIA (Muscle pain in leg). On 15-Apr-2021, PAIN IN EXTREMITY (Sore arm for a day and a half) had resolved. At the time of the report, HEADACHE (Headache) and MYALGIA (Muscle pain in leg) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 1st dose 46 days ago and still has yet to receive the 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 1st dose 46 days ago and still has yet to receive the 2nd dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 1st dose 46 days ago and still has yet to receive the 2nd dose) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Reporter did not allow further contact
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Feeling abnormal, Induration, Pain, Vaccination site nodule
Clinical narrative: Arm had a knot the size of a baseball; Really hard; Painful; Could not lay on side of body; Felt like her body was rejecting vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE NODULE (Arm had a knot the size of a baseball), INDURATION (Really hard), PAIN (Painful), DISCOMFORT (Could not lay on side of body) and FEELING ABNORMAL (Felt like her body was rejecting vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039b21a) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Apr-2021, the patient experienced VACCINATION SITE NODULE (Arm had a knot the size of a baseball), INDURATION (Really hard), PAIN (Painful), DISCOMFORT (Could not lay on side of body) and FEELING ABNORMAL (Felt like her body was rejecting vaccine). At the time of the report, VACCINATION SITE NODULE (Arm had a knot the size of a baseball), INDURATION (Really hard), PAIN (Painful), DISCOMFORT (Could not lay on side of body) and FEELING ABNORMAL (Felt like her body was rejecting vaccine) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications were reported. No treatment information was provided.   This case was linked to MOD-2021-080253 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: high grade fever; headache; This spontaneous case was reported by an other caregiver and describes the occurrence of PYREXIA (high grade fever) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, the patient experienced PYREXIA (high grade fever) and HEADACHE (headache). At the time of the report, PYREXIA (high grade fever) and HEADACHE (headache) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event were not provided.  No laboratory investigations were provided. The Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeding disorder
Clinical narrative: loose stools (bowels); has not been able to eat anything; This spontaneous case was reported by an other caregiver (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (loose stools (bowels)) and FEEDING DISORDER (has not been able to eat anything) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (loose stools (bowels)) and FEEDING DISORDER (has not been able to eat anything). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE (PEPTO-BISMOL) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (loose stools (bowels)) and FEEDING DISORDER (has not been able to eat anything) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Reporter stated that his aunt received the second dose of the Moderna COVID-19 vaccine about 3-4 weeks ago. And  stated that his aunt has already seen two doctors and is also going to see a third one on Friday 23-APR-2021.  Concomitant medications not provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling cold, Lymphadenopathy, Paraesthesia, Specialist consultation
Clinical narrative: Tingling sensation in the left leg; Felt very cold / random cold sensation and sometimes in her arm and left side of face; Swollen lymph nodes in her armpit; Felt like it went into my leg, something float to my left leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling sensation in the left leg), FEELING ABNORMAL (Felt like it went into my leg, something float to my left leg), FEELING COLD (Felt very cold / random cold sensation and sometimes in her arm and left side of face) and LYMPHADENOPATHY (Swollen lymph nodes in her armpit) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), FLUTICASONE PROPIONATE (FLONASE [FLUTICASONE PROPIONATE]) and LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) for an unknown indication.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced FEELING ABNORMAL (Felt like it went into my leg, something float to my left leg). On 08-Apr-2021, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes in her armpit). On an unknown date, the patient experienced PARAESTHESIA (Tingling sensation in the left leg) and FEELING COLD (Felt very cold / random cold sensation and sometimes in her arm and left side of face). At the time of the report, PARAESTHESIA (Tingling sensation in the left leg), FEELING ABNORMAL (Felt like it went into my leg, something float to my left leg), FEELING COLD (Felt very cold / random cold sensation and sometimes in her arm and left side of face) and LYMPHADENOPATHY (Swollen lymph nodes in her armpit) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Specialist consultation: nerve inflammation (abnormal) The patient stated that she has been seen by her health care provider and who thinks it was nerve inflammation..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication also included aurovela. Treatment details was not provided.